The forecasted data from 2024 to 2028 shows a slight decline in tuberculosis treatment success rates in the US. Starting at 75% in 2024 and gradually decreasing to 73% by 2028, this indicates an average annual decrease reflecting ongoing challenges in maintaining or improving treatment outcomes.

Key points on future trends to watch for:

Advancements in medical treatments and technology could impact future success rates positively.
Investments in public health infrastructure may be necessary to reverse the declining trend.
Variability in success rates may arise from changes in healthcare policy or socioeconomic factors affecting access to treatment.